Kangfang Biotech: Revenue of 3.056 billion yuan in 2025, a year-on-year increase of 43.90%

Kangfang Biotech announces that 2025 revenue was RMB 3.056 billion, up 43.90% year over year; the company incurred a loss of RMB 1.141 billion during the year, compared with a loss of RMB 501 million in the same period of 2024.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin